🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Open-Label Phase 3 study to evaluate the long-term safety and efficacy of u...
Status
Completed
Location
Warner Chilcott Investigational Site
Start Date
2010-01
Trial ID
NCT01065012
This study is a Phase I, single-center, randomized, double-blind, placebo-c...
Status
Completed
Location
SGS clinical pharmacology unit
Start Date
2016-10-18
Trial ID
NCT03102567
Randomized, placebo-controlled, double-blind, parallel design, Phase 3 stud...
Status
Completed
Location
Warner Chilcott Investigational Site
Start Date
2009-09
Trial ID
NCT01037244
International, multicentre, prospective, randomized, double-blind, placebo-...
Status
Completed
Location
IMUNOGLUKAN CZ, s.r.o.
Start Date
2023-09-25
Trial ID
NCT06974747
Treatments Being Tested
This randomized, double-blind, placebo-controlled trial will evaluate the i...
Status
Completed
Location
Center of New Medical Technologies
Start Date
2022-03-02
Trial ID
NCT06163443
Adolescent idiopathic scoliosis surgery is an extensive procedure associate...
Status
Completed
Location
Boston Childrens Hospital
Start Date
2013-01
Trial ID
NCT01813058
Treatments Being Tested
The purpose of this study is to characterize the effects of 85 days treatme...
Status
Withdrawn
Location
Multiple Locations
Start Date
2015-05-20
Trial ID
NCT02410499
Treatments Being Tested
This study was conducted to determine the efficacy and safety of GWP42003 c...
Status
Completed
Location
Multiple Locations
Start Date
2012-05-09
Trial ID
NCT01562314
60 patients of radiological, biopsy proven advanced HCC (Hepatocellular car...
Status
Completed
Location
Institute of Liver & Biliary Sciences
Start Date
2014-10-01
Trial ID
NCT02259647
This is a multicenter, double-blind, randomized, phase 2 trial to investiga...
Status
Recruiting
Location
The fourth hospital of Hebei Medical University
Start Date
2024-11-15
Trial ID
NCT06576921
Treatments Being Tested